Showing 1 - 14 results of 14 for search 'Mary J. Meegan', query time: 0.04s
Refine Results
-
1
Special Issue “Anticancer Drugs 2021” by Mary J. Meegan, Niamh M. O’Boyle
Published 2022-04-01
Article -
2
-
3
Special Issue “Anticancer Drugs” by Mary J. Meegan, Niamh M. O’Boyle
Published 2019-09-01
Article -
4
Design, Synthesis and Biochemical Evaluation of Novel Selective Estrogen Receptor Ligand Conjugates Incorporating an Endoxifen-Combretastatin Hybrid Scaffold by Niall O. Keely, Miriam Carr, Bassem Yassin, Gloria Ana, David G. Lloyd, Daniela Zisterer, Mary J. Meegan
Published 2016-07-01
Article -
5
-
6
Novel Selective Estrogen Receptor Ligand Conjugates Incorporating Endoxifen-Combretastatin and Cyclofenil-Combretastatin Hybrid Scaffolds: Synthesis and Biochemical Evaluation by Patrick M. Kelly, Niall O. Keely, Sandra A. Bright, Bassem Yassin, Gloria Ana, Darren Fayne, Daniela M. Zisterer, Mary J. Meegan
Published 2017-08-01
Article -
7
-
8
Design, Synthesis and Biochemical Evaluation of Novel Ethanoanthracenes and Related Compounds to Target Burkitt’s Lymphoma by Andrew J. Byrne, Sandra A. Bright, James P. McKeown, John E. O’Brien, Brendan Twamley, Darren Fayne, D. Clive Williams, Mary J. Meegan
Published 2020-01-01
Article -
9
Antiproliferative and Tubulin-Destabilising Effects of 3-(Prop-1-en-2-yl)azetidin-2-Ones and Related Compounds in MCF-7 and MDA-MB-231 Breast Cancer Cells by Shu Wang, Azizah M. Malebari, Thomas F. Greene, Shubhangi Kandwal, Darren Fayne, Seema M. Nathwani, Daniela M. Zisterer, Brendan Twamley, Niamh M. O’Boyle, Mary J. Meegan
Published 2023-07-01
Article -
10
Synthesis, Characterisation and Mechanism of Action of Anticancer 3-Fluoroazetidin-2-ones by Azizah M. Malebari, Gabriela Duffy Morales, Brendan Twamley, Darren Fayne, Mohemmed Faraz Khan, Eavan C. McLoughlin, Niamh M. O’Boyle, Daniela M. Zisterer, Mary J. Meegan
Published 2022-08-01
Article -
11
3-Vinylazetidin-2-Ones: Synthesis, Antiproliferative and Tubulin Destabilizing Activity in MCF-7 and MDA-MB-231 Breast Cancer Cells by Shu Wang, Azizah M. Malebari, Thomas F. Greene, Niamh M. O’Boyle, Darren Fayne, Seema M. Nathwani, Brendan Twamley, Thomas McCabe, Niall O. Keely, Daniela M. Zisterer, Mary J. Meegan
Published 2019-04-01
Article -
12
Synthesis and Antiproliferative Evaluation of 3-Chloroazetidin-2-ones with Antimitotic Activity: Heterocyclic Bridged Analogues of Combretastatin A-4 by Azizah M. Malebari, Shu Wang, Thomas F. Greene, Niamh M. O’Boyle, Darren Fayne, Mohemmed Faraz Khan, Seema M. Nathwani, Brendan Twamley, Thomas McCabe, Daniela M. Zisterer, Mary J. Meegan
Published 2021-10-01
Article -
13
Synthesis and Biological Evaluation of 1-(Diarylmethyl)-1<i>H</i>-1,2,4-triazoles and 1-(Diarylmethyl)-1<i>H</i>-imidazoles as a Novel Class of Anti-Mitotic Agent for Activity in B... by Gloria Ana, Patrick M. Kelly, Azizah M. Malebari, Sara Noorani, Seema M. Nathwani, Brendan Twamley, Darren Fayne, Niamh M. O’Boyle, Daniela M. Zisterer, Elisangela Flavia Pimentel, Denise Coutinho Endringer, Mary J. Meegan
Published 2021-02-01
Article -
14
Synthesis and Pro-Apoptotic Effects of Nitrovinylanthracenes and Related Compounds in Chronic Lymphocytic Leukaemia (CLL) and Burkitt’s Lymphoma (BL) by Andrew J. Byrne, Sandra A. Bright, James. P. McKeown, Adam Bergin, Brendan Twamley, Anthony M. McElligott, Sara Noorani, Shubhangi Kandwal, Darren Fayne, Niamh M. O’Boyle, D. Clive Williams, Mary J. Meegan
Published 2023-12-01
Article